Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/25991
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorMuñoz Vahos, Carlos Horacio-
dc.contributor.authorHerrera Uribe, Sebastián-
dc.contributor.authorArbeláez Cortés, Álvaro-
dc.contributor.authorJaramillo Arroyave, Daniel-
dc.contributor.authorGonzález Naranjo, Luis Alonso-
dc.contributor.authorVásquez Duque, Gloria María-
dc.contributor.authorRestrepo Escobar, Mauricio-
dc.contributor.authorCorrea Londoño, Luis Alfonso-
dc.contributor.authorHernández Zapata, Johanna-
dc.contributor.authorVanegas García, Adriana Lucía-
dc.date.accessioned2022-02-12T16:26:46Z-
dc.date.available2022-02-12T16:26:46Z-
dc.date.issued2018-
dc.identifier.citationMuñoz-Vahos C, Herrera-Uribe S, Arbeláez-Cortés Á, et alFRI0474 Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathyAnnals of the Rheumatic Diseases 2018;77:765.spa
dc.identifier.issn0003-4967-
dc.identifier.urihttp://hdl.handle.net/10495/25991-
dc.description.abstractABSTRACT: Background Up to 88% of cocaine is tainted with levamisole, an anthelmintic withdrawn from the market due to toxicity. Since 2010 levamisole-adulterated cocaine induced vasculopathy (LACIV) patients, characterised by retiform purpura, ear necrosis, multisystemic compromise and positivity for multiple autoantibodies, have been reported. Knowing the pattern and the severity of skin involvement is essential in the approach of these patients. Objectives To describe the cutaneous manifestations of patients with LACIV and to propose a classification of skin involvement. Methods We describe the skin compromise of 30 patients with LACIV evaluated between December 2010 and May 2017. Based on this series and the review of the literature, we propose a classification according to the distribution and severity of the lesions. Results All patients were mestizo, median age of 31 (IQR 27–38), male:female ratio 5:1, time from symptoms to diagnosis 12 months (IQR 6–24). The most frequent clinical manifestations were skin lesions: ear necrosis (73%) and retiform purpura (83%) affecting the extensor part of the limbs, buttocks, face, and abdomen; sparing the scalp, palms and soles. Retiform purpura was classified in four grades according to distribution and severity (image). Skin biopsies revealed leukocytoclastic vasculitis (24%), pseudo-vasculitis (19%), thrombotic vasculopathy with leukocytoclastic vasculitis (19%), thrombotic vasculopathy with pseudo-vasculitis (19%), and pyoderma gangrenosum with vasculopathy (5%).spa
dc.format.extent1spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherBMJ Publishing Groupspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/2.5/co/*
dc.title Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathyspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Reumatología Universidad de Antioquia -GRUA-spa
dc.publisher.groupCentro de de Investigaciones Dermatológicasspa
dc.identifier.doi10.1136/annrheumdis-2018-eular.2145-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1468-2060-
oaire.citationtitleAnnals of the Rheumatic Diseasesspa
oaire.citationstartpage765spa
oaire.citationendpage765spa
oaire.citationvolume77spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc/4.0/spa
dc.publisher.placeLondres, Inglaterraspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsLevamisol-
dc.subject.decsLevamisole-
dc.subject.decsCocaína-
dc.subject.decsCocaine-
dc.description.researchgroupidCOL0010959spa
dc.description.researchgroupidCOL0130733spa
dc.relation.ispartofjournalabbrevAnn. Rheum. Dis.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
MuñozCarlos_2018_.pdfArtículo de investigación478.03 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons